S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
John J. Kim · Study
Home
/
Author
John J. Kim
2 works
· latest 2019
· 1 institutions
cluster: provisional
ORCID 0000-0001-8737-861X
Follow
Suggest an ORCID correction
h-index
2
i10
2
Citations
86
Works here
2
10
19
Most cited in this library
Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost–Utility Analysis
2019 · 73 citations
Effect Sizes in Cross-Cultural Research
2010 · 13 citations
Works
2 shown
Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost–Utility Analysis
The Oncologist
·
2019
·
4 authors
·
Open access
73
citations
Effect Sizes in Cross-Cultural Research
Cambridge University Press eBooks
·
2010
·
4 authors
·
chapter
13
citations